Neuroloxía
Servicio
Hospital Clinico Universitario de Valencia
Valencia, EspañaPublicacións en colaboración con investigadores/as de Hospital Clinico Universitario de Valencia (37)
2024
-
Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: Discover study
Multiple Sclerosis and Related Disorders, Vol. 90
-
Eptinezumab for the preventive treatment of episodic and chronic migraine: a narrative review
Frontiers in Neurology , Vol. 15
2023
-
Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study
Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193
2022
-
Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology
Frontiers in immunology, Vol. 13, pp. 842354
-
Calcitonin gene–related peptide in migraine: from pathophysiology to treatment
Neurologia, Vol. 37, Núm. 5, pp. 390-402
2021
-
1st Post-European Headache Federation Meeting: A review of the latest developments presented at the 2020 European Headache Federation Congress
Revista de Neurologia
-
Document of revision and updating of medication overuse headache (MOH)
Neurologia, Vol. 36, Núm. 3, pp. 229-240
-
Impact of the COVID-19 pandemic on the training of Spanish neurology residents
Neurology Perspectives, Vol. 1, Núm. 2, pp. 124-130
-
Opicapone for the treatment of Parkinson’s disease: real-life data in Spain
Revista de Neurologia, Vol. 73, pp. S1-S14
-
Present and future of parkinson’s disease in Spain: Parkinson-2030 delphi project
Brain Sciences, Vol. 11, Núm. 8
-
Spanish expert consensus on the use of safinamide in Parkinson's disease
Neurologia, Vol. 36, Núm. 9, pp. 666-672
-
The impact of a digital platform on migraine patient-centered outcome research. Evaluation of midolordecabeza.org, a headache website in Spanish
Headache, Vol. 61, Núm. 9, pp. 1403-1410
2020
-
Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine
Neurologia, Vol. 35, Núm. 8, pp. 568-578
-
Will neurological care change over the next 5 years due to the COVID-19 pandemic? Key informant consensus survey
Neurologia, Vol. 35, Núm. 4, pp. 252-257
2019
-
Clinical Predictors of Hyperperfusion Syndrome Following Carotid Stenting: Results From a National Prospective Multicenter Study
JACC: Cardiovascular Interventions, Vol. 12, Núm. 9, pp. 873-882
-
Evidence and experience with onabotulinumtoxinA in chronic migraine: Recommendations for daily clinical practice
Neurologia, Vol. 34, Núm. 6, pp. 408-417
-
Self-reported periodontitis and migraine: results from a multicenter, cross-sectional survey in Spain
Odontology, Vol. 107, Núm. 4, pp. 530-535
2018
-
Comorbidity between idiopathic overactive bladder and chronic migraine
Cephalalgia, Vol. 38, Núm. 3, pp. 581-584
2016
-
NEOPLASM study: Real-life use of lacosamide in patients with brain tumor-related epilepsy
Epilepsy and Behavior, Vol. 65, pp. 25-32
2014
-
Errors in recognition and management are still frequent in patients with cluster headache
European Neurology, Vol. 72, pp. 209-212